Abstract

EE173 Direct Cost Components of Lupus Nephritis in Brazilian Private Healthcare: An Expert Panel Approach

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Expert-based development of a generic HACCP-based risk management system to prevent critical negative energy balance in dairy herds
Tine Rousing ... Søren Østergaard
Preventive veterinary medicine | VOL. 175
Tine Rousing, et. al.Tine Rousing ... Søren Østergaard
15 Nov 2019
Analysis of the Features Important for the Effectiveness of Physical Activity-Related Apps for Recreational Sports: Expert Panel Approach.
Joan Dallinga ... Steven Vos
JMIR mHealth and uHealth | VOL. 6
Joan Dallinga, et. al.Joan Dallinga ... Steven Vos
18 Jun 2018
PBI16 COST MINIMIZATION ANALYSIS OF BIOSIMILAR INFLIXIMAB IN BRAZILIAN SUPLEMENTARY HEALTHCARE SYSTEM
R.F Alexandre ... T Senna
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 22
R.F Alexandre, et. al.R.F Alexandre ... T Senna
01 May 2019
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives
Camila Pepe Ribeiro De Souza ... Sheila Ouriques Martins
Value in Health Regional Issues | VOL. 8
Camila Pepe Ribeiro De Souza, et. al.Camila Pepe Ribeiro De Souza ... Sheila Ouriques Martins
09 Jun 2015
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Methods for measuring and valuing informal care: A systematic review and meta-analysis in stroke
Neha Das ... Lan Gao
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Neha Das, et. al.Neha Das ... Lan Gao
06 Jul 2024
View more papers